| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |